MolDock applied to structure-based virtual screening

Current Drug Targets

Volumn 11, Issue 3, 2010, Pages 327-334

  De Azevedo Jr , Walter Filgueira ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

CDK2; Docking; Evolutionary algorithms; Molecular docking; PNP; Protein ligand; Shikimate kinase; Structure based virtual screening

Indexed keywords

CYCLIN DEPENDENT KINASE 2; PURINE NUCLEOSIDE PHOSPHORYLASE; SHIKIMIC ACID;

BIOLOGY; EVOLUTIONARY ALGORITHM; HUMAN; MOLECULAR DOCKING; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SCREENING; THEORY; VIRTUAL REALITY;

ALGORITHMS; BINDING SITES; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING;

EID: 77950829861     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945010790711941     Document Type: Review

References (83)

1. De Azevedo Jr WF, Dias R. Computational methods for calculation ligand-binding affinity. Curr Drug Targets 2008; 9: 1031-1039
2. Dias R, De Azevedo Jr WF. Molecular docking algorithms. Curr Drug Targets 2008; 9: 1040-1047
3. Dias R, Timmers LFSM, Caceres RA, De Azevedo Jr WF. Evaluation of molecular docking using polynomial empirical scoring functions. Curr Drug Targets 2008; 9: 1062-1070
4. Canduri F, De Azevedo Jr WF. Protein crystallography in drug discovery. Curr Drug Targets 2008; 9: 1048-1053
5. De Azevedo Jr WF, Dias R. Experimental approaches to evaluate the thermodynamics of protein-drug interactions. Curr Drug Targets 2008; 9: 1071-1076
6. Berman HM. The Protein Data Bank: a historical perspective. Acta Crystallogr A 2008; 64: 88-95.
7. Westbrook J, Ito N, Nakamura H, Henrick K, Berman HM. PDBML: the representation of archival macromolecular structure data in XML. Bioinformatics 2005; 21: 988-992 (Pubitemid 40467920)
8. Wang R, Fang X, Lu Y, Yang CY, Wang S. The PDBbind database: methodologies and updates. J Med Chem 2005; 48: 4111-4119
9. Wang R, Fang X, Lu Y, Wang S. The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J Med Chem 2004; 47: 2977-2980 (Pubitemid 38702694)
10. Puvanendrampillai D, Mitchell JB. L/D Protein Ligand Database (PLD): additional understanding of the nature and specificity of protein-ligand complexes. Bioinformatics 2003; 19: 1856-1857.
11. Block P, Sotriffer CA, Dramburg I, Klebe G. AffinDB: a freely accessible database of affinities for protein-ligand complexes from the PDB. Nucleic Acids Res 2006; 34: D522-6.
12. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK. Nucleic Acids Res 2007; 35(D): 198-201.
13. Irwin JJ, Shoichet BK. ZINC - a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005; 45: 177-182
14. Rosania GR, Crippen G, Woolf P, States D, Shedden K. A cheminformatic toolkit for mining biomedical knowledge. Pharm Res 2007; 24: 1791-1802 (Pubitemid 47389234)
15. Chen JH, Linstead E, Swamidass SJ, Wang D, Baldi P. ChemDB update - full-text search and virtual chemical space. Bioinformatics 2007; 23: 2348-2351 (Pubitemid 47423878)
16. Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006; 34: 668-672
17. Wishart DS. DrugBank and its relevance to pharmacogenomics. Pharmacogenetics 2008; 9: 1155-1162
18. Ewing TJ, Makino S, Skillman AG, Kuntz ID. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des 2001; 15: 411-428 (Pubitemid 32452109)
19. Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 1998; 19: 1639-1662
20. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 1996; 9: 1-5.
21. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD. Improved protein-ligand docking using GOLD. Proteins 2003; 52: 609-623
22. Joy S, Nair PS, Hariharan R, Pillai MR. Detailed comparison of the protein-ligand docking efficiencies of GOLD, a commercial package and ArgusLab, a licensable freeware. In Silico Biol 2006; 6: 601-605 (Pubitemid 47028648)
23. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996; 261: 470-489 (Pubitemid 26335901)
24. Kramer B, Rarey M, Lengauer T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 1999; 37: 228-241
25. Chen R, Li L, Weng Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins 2003; 52: 80-87
26. Pierce B, Tong W, Weng Z. M-ZDOCK: a grid-based approach for Cn symmetric multimer docking. Bioinformatics 2005; 21: 1472-1478 (Pubitemid 40542702)
27. Sauton N, Lagorce D, Villoutreix BO, Miteva MA. MS-DOCK: accurate multiple conformation generator and rigid docking protocol for multi-step virtual ligand screening. BMC Bioinformatics 2008; 9: 184-196 (Pubitemid 351627347)
28. Jain AN. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem 2003; 46: 499-511.
29. Liu M, Wang S. MCDOCK: a Monte Carlo simulation approach to the molecular docking problem. J Comput Aided Mol Des 1999; 13: 435-451 (Pubitemid 29395560)
30. Thomsen R, Christensen MH. MolDock: a new technique for highaccuracy molecular docking. J Med Chem 2006; 49: 3315-3321 (Pubitemid 43830529)
31. Yang JM, Chen CC. GEMDOCK: a generic evolutionary method for molecular docking. Proteins 2004; 55: 288-304.
32. Goldberg DE. Genetic algorithms in search, optimization, and machine learning, New York: Addilson-Wiley 1989.
33. Leach AR. Molecular Modelling. Principles and Applications, 2nd ed. Essex: Pearson Prentice Hall 2001.
34. Pang T. An Introduction to Computational Physics, 2nd ed. New York: Cambridge University Press 2006.
35. Shoemake K. In Graphics Gems III; Kirk D, Ed. Boston: AP Professional (Academic Press) 1992; pp 124-132
36. De Azevedo Jr WF, Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E, Kim SH. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci USA 1996; 93: 2735-2740
37. De Azevedo Jr WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 1997; 243: 518-526
38. De Azevedo Jr WF, Canduri F, da Silveira NJ. Structural basis for inhibition of Cyclin-Dependent Kinase 9 by flavopiridol. Biochem Biophys Res Commun 2002; 293: 566-571
39. De Azevedo Jr WF, Gaspar RT, Canduri F, Camera Jr JC, Silveira NJF. Molecular model of cyclin-dependent kinase 5 complexed with roscovitine. Biochem Biophys Res Commun 2002; 297: 1154-1158 (Pubitemid 35216368)
40. Canduri F, Uchoa HB, De Azevedo Jr WF. Molecular models of cyclin-dependent kinase 1 complexed with inhibitors. Biochem Biophys Res Commun 2004; 324: 661-666
41. Canduri F, De Azevedo Jr WF. Structural basis for interaction of inhibitors with Cyclin-Dependent Kinase 2. Curr Computer-Aided Drug Des 2005; 1: 53-64.
42. Manhani KK, Arcuri HA, Da Silveira NJ, Uchôa HB, De Azevedo Jr WF, Canduri F. Molecular models of protein kinase 6 from Plasmodium falciparum. J Mol Mod 2005; 12: 42-48
43. Krystof V, Cankar P, Hajduch M, et al. 4-Arylazo-3,5-diamino-1Hpyrazole CDK Inhibitors: SAR study, crystal structure in complex with cdk2, selectivity, and cellular effects. J Med Chem 2006; 49: 6500-6509
44. Leopoldino AM, Canduri F, Cabral H, et al. Expression, purification, and circular dichroism analysis of human CDK9. Protein Expr Purif 2006; 47: 614-620
45. Canduri F, Perez PC, Caceres RA, De Azevedo Jr WF. Protein kinases as targets for antiparasitic chemotherapy drugs. Curr Drug Targets 2007; 8: 389-398
46. Canduri F, Perez PC, Caceres RA, De Azevedo Jr WF. CDK9 a potential target for drug development. Med Chem 2008; 4: 210-218
47. Perez PC, Caceres RA, Canduri F, De Azevedo Jr WF. Molecular modeling and dynamics simulation of human cyclin-dependent kinase 3 complexed with inhibitors. Comput Biol Med 2009; 39: 130-140
48. Gray NS, Wodicka L, Thunnissen AM, et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 1998; 281: 533-538
49. De Azevedo Jr. WF, Canduri F, Santos DM, et al. Crystal structure of human purine nucleoside phosphorylase at 2.3 A resolution. Biochem Biophys Res Commun 2003; 308: 545-552 (Pubitemid 36945527)
50. Santos DM, Canduri F, Pereira JH, et al. Crystal structure of human purine nucleoside phosphorylase complexed with acyclovir. Biochem Biophys Res Commun 2003; 308: 553-559 (Pubitemid 36945528)
51. De Azevedo Jr WF, Canduri F, Dos Santos DM, et al. Structural basis for inhibition of human PNP by immucillin-H. Biochem Biophys Res Commun 2003; 309: 917-922
52. De Azevedo Jr WF, Santos GC, Santos DM, et al. Docking and small angle X-ray scattering studies of purine nucleoside phosphorylase. Biochem Biophys Res Commun 2003; 309: 923-928
53. De Azevedo Jr WF, Canduri F, dos Santos DM, et al. Crystal structure of human PNP complexed with guanine. Biochem Biophys Res Commun 2003; 312: 767-772
54. Canduri F, dos Santos DM, Silva RG, et al. Structures of human Purine Nucleoside Phosphorylase complexed with Inosine and ddI. Biochem Biophys Res Commun 2004; 313: 907-914
55. Da Silveira NJF, Uchoa HB, Canduri F, et al. Structural Bioinformatics Study of PNP from Schistosoma mansoni. Biochem Biophys Res Commun 2004; 322: 100-104
56. Nolasco DO, Canduri F, Pereira JH, et al. Crystallographic structure of PNP from Mycobacterium tuberculosis at 1.9 A resolution. Biochem Biophys Res Commun 2004; 324: 789-794
57. Canduri F, Fadel V, Dias MVB, et al. Crystal structure of human PNP complexed with hypoxanthine and sulfate ion. Biochem Biophys Res Commun 2005; 326: 335-338
58. Canduri F, Fadel V, Basso LA, Palma MS, Santos DS, De Azevedo Jr WF. New catalytic mechanism for human purine nucleoside phosphorylase. Biochem Biophys Res Commun 2005; 327: 646-649
59. Canduri F, Silva RG, dos Santos DM, et al. Structure of human PNP complexed with ligands. Acta Crystallogr D Biol Crystallogr 2005; 61: 856-862
60. Silva RG, Pereira JH, Canduri F, De Azevedo Jr WF, Basso LA, Santos DS. Kinetics and crystal structure of human purine nucleoside phosphorylase in complex with 7-methyl-6-thioguanosine. Arch Biochem Biophys 2005; 442: 49-58. (Pubitemid 41330993)
61. De Azevedo Jr WF, Canduri F, Basso LA, Palma MS, Santos DS. Determining the structural basis for specificity of ligands using crystallographic screening. Cell Biochem Biophys 2006; 44: 405-411 (Pubitemid 43780395)
62. Timmers LFSM, Caceres RA, Vivan, AL, et al. Structural studies of human purine nucleoside phosphorylase: towards a new specific empirical scoring function. Arch Biochem Biophys 2008; 479: 28-38.
63. Caceres RA, Saraiva Timmers LF, Dias R, Basso LA, Santos DS, De Azevedo Jr WF. Molecular modeling and dynamics simulations of PNP from Streptococcus agalactiae. Bioorg Med Chem 2008; 16: 4984-4993
64. Timmers LFSM, Caceres RA, Basso LA, Santos DS, De Azevedo Jr WF. Structural Bioinformatics Study of PNP from Listeria monocytogenes. Prot Pept Lett 2008; 15: 843-849
65. Pauli I, Timmers LFSM, Caceres RA, Basso LA, Santos DS, De Azevedo Jr WF. Molecular modeling and dynamics studies of Purine Nucleoside Phosphorylase from Bacteroides fragilis. J Mol Model 2009; 15(8): 913-922
66. Timmers LFSM, Caceres RA, Dias R, Basso LA, Santos DS, De Azevedo Jr WF. Molecular modeling, dynamics and docking studies of Purine Nucleoside Phosphorylase from Streptococcus pyogenes. Biophys Chem 2009; 142: 7-16.
67. De Azevedo Jr WF, Canduri F, Simões de Oliveira J, et al. Molecular model of shikimate kinase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 2002; 295: 142-148
68. Pereira JH, Canduri F, de Oliveira JS, et al. Structural Bioinformatics Study of EPSP synthase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 2003; 312: 608-614
69. Pereira JH, de Oliveira JS, Canduri F, et al. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid. Acta Crystallogr D Biol Crystallogr 2004; 60: 2310-2319
70. Arcuri HA, Canduri F, Pereira JH, et al. Molecular models for shikimate pathway enzymes of Xylella fastidiosa. Biochem Biophys Res Commun 2004; 320: 979-991
71. Borges JC, Pereira JH, Vasconcelos IB, et al. Phosphate closes the solution structure of the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Mycobacterium tuberculosis. Arch Biochem Biophys 2006; 452: 156-164
72. Pereira JH, Vasconcelos IB, Oliveira JS, et al. Shikimate kinase: A potential target for development of novel antitubercular agents. Curr Drug Targets 2007; 8: 459-468 (Pubitemid 46381296)
73. Dias MVB, Faim LM, Vasconcelos IB, et al. Effects of magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis. Acta Crystallograph Sect F Struct Biol Cryst Commun 2007; 63: 1-6.
74. Dias MVB, Ely F, Palma MS, De Azevedo Jr WF, Basso LA, Santos DS. Chorismate synthase: An attractive target for drug development against orphan diseases. Curr Drug Targets 2007; 8: 437-444 (Pubitemid 46381294)
75. Pauli I, Caceres RA, De Azevedo Jr WF. Molecular modeling and dynamics studies of shikimate kinase from Bacillus anthracis. Bioorg Med Chem 2008; 16: 8098-8108
76. Arcuri HA, Borges JC, Fonseca IO, et al. Structural studies of shikimate 5-dehydrogenase from Mycobacterium tuberculosis. Proteins 2008; 72: 720-730
77. Dias MV, Borges JC, Ely F, et al. Structure of chorismate synthase from Mycobacterium tuberculosis. J Struct Biol 2006; 154: 130-143
78. Marques MR, Vaso A, Neto JR, et al. Dynamics of glyphosateinduced conformational changes of Mycobacterium tuberculosis 5-enolpyruvylshikimate-3- phosphate synthase (EC 2.5.1.19) determined by hydrogen-deuterium exchange and electrospray mass spectrometry. Biochemistry 2008; 47: 7509-7522
79. Marques MR, Pereira JH, Oliveira JS, et al. The inhibition of 5-enolpyruvylshikimate-3-phosphate synthase as a model for development of novel antimicrobials. Curr Drug Targets 2007; 8: 445-457
80. Barcellos GB, Caceres RA, De Azevedo Jr WF. Structural studies of shikimate dehydrogenase from Bacillus anthracis complexed with cofactor NADP. J Mol Model 2009; 15: 147-155
81. De Amorim HL, Caceres RA, Netz PA. Linear interaction energy (LIE) method in lead discovery and optimization. Curr Drug Targets 2008; 9: 1100-1105
82. Okimoto N, Futatsugi N, Fuji H, et al. High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations. PLoS Comput Biol 2009; 5: e1000528.
83. Canduri F, Teodoro LG, Fadel V, et al. Structure of human uropepsin at 2.45 A resolution. Acta Crystallogr D Biol Crystallogr 2001; 57: 1560-1570